CN106858141A - A kind of feed produced rich in the polyunsaturated fatty acids of ω 3 and Co-Q10 egg - Google Patents
A kind of feed produced rich in the polyunsaturated fatty acids of ω 3 and Co-Q10 egg Download PDFInfo
- Publication number
- CN106858141A CN106858141A CN201710127314.1A CN201710127314A CN106858141A CN 106858141 A CN106858141 A CN 106858141A CN 201710127314 A CN201710127314 A CN 201710127314A CN 106858141 A CN106858141 A CN 106858141A
- Authority
- CN
- China
- Prior art keywords
- parts
- egg
- feed
- vitamin
- polyunsaturated fatty
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 title claims abstract description 54
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 title abstract description 5
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims description 35
- 238000002360 preparation method Methods 0.000 claims description 20
- 239000000463 material Substances 0.000 claims description 19
- 239000000843 powder Substances 0.000 claims description 17
- 240000006240 Linum usitatissimum Species 0.000 claims description 16
- 235000004431 Linum usitatissimum Nutrition 0.000 claims description 16
- 235000004426 flaxseed Nutrition 0.000 claims description 15
- 235000004347 Perilla Nutrition 0.000 claims description 14
- 239000002253 acid Substances 0.000 claims description 14
- 235000012054 meals Nutrition 0.000 claims description 14
- 235000001855 Portulaca oleracea Nutrition 0.000 claims description 13
- 241000219823 Medicago Species 0.000 claims description 12
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 claims description 12
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 12
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 12
- 240000008042 Zea mays Species 0.000 claims description 12
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 12
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 12
- 150000001875 compounds Chemical class 0.000 claims description 12
- 235000005822 corn Nutrition 0.000 claims description 12
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 12
- 235000010755 mineral Nutrition 0.000 claims description 12
- 239000011707 mineral Substances 0.000 claims description 12
- 239000004575 stone Substances 0.000 claims description 12
- 239000011573 trace mineral Substances 0.000 claims description 12
- 235000013619 trace mineral Nutrition 0.000 claims description 12
- 239000002131 composite material Substances 0.000 claims description 11
- 235000012424 soybean oil Nutrition 0.000 claims description 11
- 239000003549 soybean oil Substances 0.000 claims description 11
- 235000013312 flour Nutrition 0.000 claims description 10
- 239000000470 constituent Substances 0.000 claims description 9
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 8
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 8
- MJVAVZPDRWSRRC-UHFFFAOYSA-N Menadione Chemical compound C1=CC=C2C(=O)C(C)=CC(=O)C2=C1 MJVAVZPDRWSRRC-UHFFFAOYSA-N 0.000 claims description 8
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 8
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 8
- 108010011619 6-Phytase Proteins 0.000 claims description 6
- 235000019743 Choline chloride Nutrition 0.000 claims description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 6
- 239000003963 antioxidant agent Substances 0.000 claims description 6
- 230000003078 antioxidant effect Effects 0.000 claims description 6
- 235000006708 antioxidants Nutrition 0.000 claims description 6
- 229930182817 methionine Natural products 0.000 claims description 6
- 235000006109 methionine Nutrition 0.000 claims description 6
- 229940085127 phytase Drugs 0.000 claims description 6
- 150000003839 salts Chemical class 0.000 claims description 6
- 239000011782 vitamin Substances 0.000 claims description 6
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 claims description 5
- WIGIZIANZCJQQY-UHFFFAOYSA-N 4-ethyl-3-methyl-N-[2-[4-[[[(4-methylcyclohexyl)amino]-oxomethyl]sulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide Chemical group O=C1C(CC)=C(C)CN1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCC(C)CC2)C=C1 WIGIZIANZCJQQY-UHFFFAOYSA-N 0.000 claims description 5
- 239000004470 DL Methionine Substances 0.000 claims description 5
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 claims description 5
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 claims description 5
- 229960003178 choline chloride Drugs 0.000 claims description 5
- 235000019700 dicalcium phosphate Nutrition 0.000 claims description 5
- FFEARJCKVFRZRR-UHFFFAOYSA-N methionine Chemical compound CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 claims description 5
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 5
- 235000002639 sodium chloride Nutrition 0.000 claims description 5
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 4
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 4
- 229930003779 Vitamin B12 Natural products 0.000 claims description 4
- 229930003471 Vitamin B2 Natural products 0.000 claims description 4
- 229930003427 Vitamin E Natural products 0.000 claims description 4
- 235000020958 biotin Nutrition 0.000 claims description 4
- 239000011616 biotin Substances 0.000 claims description 4
- 229960002685 biotin Drugs 0.000 claims description 4
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 claims description 4
- 229960000304 folic acid Drugs 0.000 claims description 4
- 235000019152 folic acid Nutrition 0.000 claims description 4
- 239000011724 folic acid Substances 0.000 claims description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 4
- 235000001968 nicotinic acid Nutrition 0.000 claims description 4
- 229960003512 nicotinic acid Drugs 0.000 claims description 4
- 239000011664 nicotinic acid Substances 0.000 claims description 4
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 4
- 229960002477 riboflavin Drugs 0.000 claims description 4
- 235000019163 vitamin B12 Nutrition 0.000 claims description 4
- 239000011715 vitamin B12 Substances 0.000 claims description 4
- 235000019164 vitamin B2 Nutrition 0.000 claims description 4
- 239000011716 vitamin B2 Substances 0.000 claims description 4
- 235000019158 vitamin B6 Nutrition 0.000 claims description 4
- 239000011726 vitamin B6 Substances 0.000 claims description 4
- 235000019165 vitamin E Nutrition 0.000 claims description 4
- 239000011709 vitamin E Substances 0.000 claims description 4
- 229940046009 vitamin E Drugs 0.000 claims description 4
- 235000012711 vitamin K3 Nutrition 0.000 claims description 4
- 239000011652 vitamin K3 Substances 0.000 claims description 4
- 229940011671 vitamin b6 Drugs 0.000 claims description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 3
- 244000063299 Bacillus subtilis Species 0.000 claims description 3
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 3
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 3
- 244000057717 Streptococcus lactis Species 0.000 claims description 3
- 235000014897 Streptococcus lactis Nutrition 0.000 claims description 3
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 3
- 229930003451 Vitamin B1 Natural products 0.000 claims description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 3
- 229910052802 copper Inorganic materials 0.000 claims description 3
- 239000010949 copper Substances 0.000 claims description 3
- 229910052742 iron Inorganic materials 0.000 claims description 3
- 239000011669 selenium Substances 0.000 claims description 3
- 229910052711 selenium Inorganic materials 0.000 claims description 3
- 229960003495 thiamine Drugs 0.000 claims description 3
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 3
- 235000019155 vitamin A Nutrition 0.000 claims description 3
- 239000011719 vitamin A Substances 0.000 claims description 3
- 235000010374 vitamin B1 Nutrition 0.000 claims description 3
- 239000011691 vitamin B1 Substances 0.000 claims description 3
- 229940045997 vitamin a Drugs 0.000 claims description 3
- 239000011701 zinc Substances 0.000 claims description 3
- 229910052725 zinc Inorganic materials 0.000 claims description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 2
- 150000001336 alkenes Chemical class 0.000 claims description 2
- 229910052799 carbon Inorganic materials 0.000 claims description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims description 2
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 claims description 2
- 244000124853 Perilla frutescens Species 0.000 claims 4
- 244000234609 Portulaca oleracea Species 0.000 claims 2
- 241001478240 Coccus Species 0.000 claims 1
- 210000003608 fece Anatomy 0.000 claims 1
- 210000000936 intestine Anatomy 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 4
- 235000013601 eggs Nutrition 0.000 description 63
- 238000012360 testing method Methods 0.000 description 14
- 210000002969 egg yolk Anatomy 0.000 description 13
- 238000004519 manufacturing process Methods 0.000 description 13
- 241000219304 Portulacaceae Species 0.000 description 11
- 241000229722 Perilla <angiosperm> Species 0.000 description 10
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 6
- 230000003712 anti-aging effect Effects 0.000 description 6
- 125000001931 aliphatic group Chemical group 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 208000003643 Callosities Diseases 0.000 description 4
- 102000002322 Egg Proteins Human genes 0.000 description 4
- 108010000912 Egg Proteins Proteins 0.000 description 4
- 241000287828 Gallus gallus Species 0.000 description 4
- 206010020649 Hyperkeratosis Diseases 0.000 description 4
- 240000007594 Oryza sativa Species 0.000 description 4
- 235000007164 Oryza sativa Nutrition 0.000 description 4
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 4
- 235000013330 chicken meat Nutrition 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 230000002526 effect on cardiovascular system Effects 0.000 description 4
- 210000003278 egg shell Anatomy 0.000 description 4
- 235000019197 fats Nutrition 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 235000009566 rice Nutrition 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 3
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 3
- 229910021536 Zeolite Inorganic materials 0.000 description 3
- 235000017471 coenzyme Q10 Nutrition 0.000 description 3
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 235000019161 pantothenic acid Nutrition 0.000 description 3
- 239000011713 pantothenic acid Substances 0.000 description 3
- 229940055726 pantothenic acid Drugs 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 3
- 239000010457 zeolite Substances 0.000 description 3
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 206010067482 No adverse event Diseases 0.000 description 2
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 239000005515 coenzyme Substances 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 235000021050 feed intake Nutrition 0.000 description 2
- 235000021323 fish oil Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 229960004488 linolenic acid Drugs 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 239000006041 probiotic Substances 0.000 description 2
- 235000018291 probiotics Nutrition 0.000 description 2
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 2
- 229940091258 selenium supplement Drugs 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- AZJQQNWSSLCLJN-UHFFFAOYSA-N 2-ethoxyquinoline Chemical compound C1=CC=CC2=NC(OCC)=CC=C21 AZJQQNWSSLCLJN-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 241000003595 Aurantiochytrium limacinum Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- PQMOXTJVIYEOQL-UHFFFAOYSA-N Cumarin Natural products CC(C)=CCC1=C(O)C(C(=O)C(C)CC)=C(O)C2=C1OC(=O)C=C2CCC PQMOXTJVIYEOQL-UHFFFAOYSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical group OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- SBJKKFFYIZUCET-JLAZNSOCSA-N Dehydro-L-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(=O)C1=O SBJKKFFYIZUCET-JLAZNSOCSA-N 0.000 description 1
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical group [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- FSOGIJPGPZWNGO-UHFFFAOYSA-N Meomammein Natural products CCC(C)C(=O)C1=C(O)C(CC=C(C)C)=C(O)C2=C1OC(=O)C=C2CCC FSOGIJPGPZWNGO-UHFFFAOYSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 244000297179 Syringa vulgaris Species 0.000 description 1
- 235000004338 Syringa vulgaris Nutrition 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003026 anti-oxygenic effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940110767 coenzyme Q10 Drugs 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 229910000366 copper(II) sulfate Inorganic materials 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 235000020667 long-chain omega-3 fatty acid Nutrition 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- ISPYRSDWRDQNSW-UHFFFAOYSA-L manganese(II) sulfate monohydrate Chemical compound O.[Mn+2].[O-]S([O-])(=O)=O ISPYRSDWRDQNSW-UHFFFAOYSA-L 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229940029985 mineral supplement Drugs 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 238000001543 one-way ANOVA Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Substances OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
- -1 phosphoric acid hydrogen Chemical class 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 235000021085 polyunsaturated fats Nutrition 0.000 description 1
- 239000001230 potassium iodate Substances 0.000 description 1
- 235000006666 potassium iodate Nutrition 0.000 description 1
- JLKDVMWYMMLWTI-UHFFFAOYSA-M potassium iodate Chemical compound [K+].[O-]I(=O)=O JLKDVMWYMMLWTI-UHFFFAOYSA-M 0.000 description 1
- 229940093930 potassium iodate Drugs 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- 229960001471 sodium selenite Drugs 0.000 description 1
- 239000011781 sodium selenite Substances 0.000 description 1
- 235000015921 sodium selenite Nutrition 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 235000021404 traditional food Nutrition 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- 239000011686 zinc sulphate Substances 0.000 description 1
- 235000009529 zinc sulphate Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/21—Streptococcus, lactococcus
- A23V2400/231—Lactis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
- Y02P60/80—Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
- Y02P60/87—Re-use of by-products of food processing for fodder production
Landscapes
- Fodder In General (AREA)
- Feed For Specific Animals (AREA)
Abstract
The invention provides a kind of feed produced rich in the polyunsaturated fatty acids of ω 3 and Co-Q10 egg.After feeding laying hen 2 weeks with the feed, the content of polyunsaturated fatty acid of total ω 3 is obtained in that for 0.5 % ~ 1.2 %, DHA（DHA）Content is 0.12 % ~ 0.25 %, and Co-Q10 content is the egg of 2.5 ~ 4.0 micro- gram grams, and its content is respectively 7.1 ~ 17.1 times, 3.0 ~ 6.3 times, 2.5 ~ 4.0 times of common egg.This egg rich in the polyunsaturated fatty acids of ω 3 and Co-Q10 has good health-care effect, and shelf-stable to people, it is easy to promote.
Description
Technical field
The present invention relates to a kind of feed, omega-3 polyunsaturated fatty acids and Co-Q10 are rich in more particularly, to one kind production
The feed of egg.
Background technology
With the development of society, the dietary structure of the mankind there occurs great variety, cause obesity, diabetes, cardiovascular and cerebrovascular
The incidence of disease chronic diseases substantially increases.By the content and coenzyme that improve omega-3 polyunsaturated fatty acids in meals
The content of Q10, can prevent and treat cardiovascular and cerebrovascular disease, anti-aging, remain healthy.
Omega-3 polyunsaturated fatty acids mainly includes alpha-linolenic acid, DHA and EPA, can effectively reduce mankind's cardiovascular and cerebrovascular
The incidence of disease, while the intelligence of infant can be improved, improve eyesight, prevention senile dementia etc..Various countries' sanitary machine
View is built, adult needs 1400 ~ 2500 milligrams of omega-3 polyunsaturated fatty acidses of intake daily, and the recommendation of wherein DHA and EPA is taken the photograph
Enter amount for 140 ~ 600 mg/days.ω -3 polyunsaturated fat is rich in deep-sea fish, linseed, deep sea fish oil and linseed oil
Acid, but it is difficult to include these foods in the ordinary meal of most crowds.Necessary amino rich in needed by human body in egg
The nutriments such as acid, aliphatic acid, vitamin, mineral matter, are the daily necessitys of consumer, are also omega-3 polyunsaturated fatty acids
Good carrier.By nutrition regulation means, linseed, microalgae, fish oil etc. are added in egg feedstuff, enrichment can be produced
The egg of omega-3 polyunsaturated fatty acids.
Co-Q10 is one of indispensable important physiological activator of human health, with prevention and treatment painstaking effort
The developed countries such as the functions such as pipe disease, raising body immunity, enhancing oxidation resistance, anti-aging, America and Europe are extensive by its
As nutrient and healthcare products and food additives.Co-Q10 in zooblast is primarily present on mitochondrial inner membrane, in body energy
Play electro transfer and transmission in the forming process of quantity of material ATP.In addition to the generation of ATP is participated in, the Co-Q10 of reduced form
（That is panthenol）It is a kind of effective antioxidant, lipid peroxidation can be prevented, reduces free radical for lipid, DNA and albumen
The oxidative damage of matter, alleviates oxidative stress.Human body itself can synthesizing coenzyme Q 10, its content in adult human body is about
0.5 ~ 1.5 gram.Co-Q10 content in people 19-20 Sui reaches peak value, and the content highest in most organs that consume energy, such as
Heart, liver, nervous system, kidney and pancreas.However, with advancing age, the yield of Co-Q10 is gradually reduced；Arrive
After 40 years old, the content of internal Co-Q10 has been greatly reduced.Therefore, in order to improve function of human body, nutritionist recommends adult
The extra supplement Co-Q10 outside conventional dietary.Co-Q10 is liposoluble substance, by nutrition regulation means, in egg feedstuff
Addition Co-Q10 is obtained in that the egg of enrichment Co-Q10.
For modern, especially middle-aged and old cardiovascular and cerebrovascular diseases are occurred frequently, work and life stress is big, anti-aging demand
Vigorous the characteristics of, on the nutritive value of this traditional food of egg, developing one kind can produce rich in ω -3 how unsaturateds
The feed of aliphatic acid and Co-Q10 egg, while ensure the storage stability of scrambled egg product, for the health for improving China resident
Level has far reaching significance.
The content of the invention
The present invention is to solve modern, especially the elderly is to omega-3 polyunsaturated fatty acids and the spy of Co-Q10
Different demand.
To solve the above problems, omega-3 polyunsaturated fatty acids and Co-Q10 chicken are rich in the invention provides one kind production
The feed of egg.
A kind of feed produced rich in omega-3 polyunsaturated fatty acids and Co-Q10 egg, is made up of following main component：
Corn, dregs of beans, soybean oil, linseed, purple perilla seed, alfalfa meal, stone flour, functional premixing material.
The mass parts of the main component are：490 ~ 550 parts of corn, 180 ~ 200 parts of dregs of beans, 5 ~ 15 parts of soybean oil, linseed 50 ~
100 parts, 10 ~ 80 parts of purple perilla seed, 20 ~ 50 parts of alfalfa meal, 80 ~ 90 parts of stone flour, 45 ~ 60 parts of functional premixing material.
With can further be optimized for：490 parts of corn, 180 parts of dregs of beans, 15 parts of soybean oil, 80 parts of linseed, purple perilla seed 50
Part, 50 parts of alfalfa meal, 80 parts of stone flour, 55 parts of functional premixing material.
Being formulated optimal case is：Be the g of corn 490 per the mass parts in kilogram of feed, the g of dregs of beans 180, the g of soybean oil 15,
The g of linseed 80, the g of purple perilla seed 50, the g of alfalfa meal 50, the g of stone flour 80, the g of functional premixing material 55.
The functional premixing material constituent is：Co-Q10, microalgae powder, purslane, calcium monohydrogen phosphate, Choline Chloride, food
Salt, DL- METHIONINE, phytase, antioxidant, B B-complex, composite mineral matter trace element and compound micro-ecological preparation.
The present invention is calculated with feed total weight parts, and each component and its mass parts are in the functional premixing material：Co-Q10
Using 0.2 ~ 0.6 part, 10 ~ 20 parts of microalgae powder, 5 ~ 15 parts of purslane, 12 ~ 14 parts of calcium monohydrogen phosphate, 1 ~ 3 part of Choline Chloride, salt
3.0 ~ 3.5 parts, 1 ~ 2 part of DL- METHIONINE, 0.05 ~ 0.1 part of phytase, 0.2 ~ 0.4 part of antioxidant, B B-complex 0.2 ~
0.35 part, 2 ~ 2.5 parts of composite mineral matter trace element, 1 ~ 1.5 part of compound micro-ecological preparation, remainder be carrier.
The constituent of the B B-complex is：Vitamin A, vitamine D3, vitamin E, Vitamin K3, vitamin
B1, vitamin B2, vitamin B6, vitamin B12, biotin, nicotinic acid, pantothenic acid, folic acid.
The constituent of composite mineral matter trace element is：Copper, iron, zinc, manganese, iodine, selenium.
The constituent of the compound micro-ecological preparation is：VREF, Lactococcus lactis and bacillus subtilis.
A kind of feed produced rich in omega-3 polyunsaturated fatty acids and Co-Q10 egg, it is characterised in that by this feed
After Direct-fed laying hen 2 weeks, total omega-3 polyunsaturated fatty acids content is can obtain for 0.5 % ~ 1.2 %, 22 carbon six
Olefin(e) acid（DHA）Content is 0.12 % ~ 0.25 %, and Co-Q10 content is the egg of 2.5 ~ 4.0 micro- gram grams.
Co-Q10 purity of the present invention is 98%, concretely the coenzyme of Zhejiang NHU Company Ltd's production
Q10 products.
Microalgae powder of the present invention is natural schizochytrium limacinum dry powder, its long-chain omega-3 polyunsaturated fatty acids（DHA+
EPA）Content exceedes the 40% of total fatty acid content.
The preparation method of purslane of the present invention is to take fresh purslane, removes undesirable root and impurity, is first refrigerated to zero
Lower less than 5 DEG C, further take out drying.Purslane after drying is crushed with 8.0 mm sieves, to improve active material in purslane
Utilization rate.
Calculated with feed total weight parts, each component and its mass parts are in B B-complex of the present invention：Vitamin A
>=7500 IU/kg, vitamine D3 >=2500 IU/kg, vitamin E >=11.5 mg/kg, Vitamin K3 >=1 mg/kg, dimension life
Plain B1 >=1.55 mg/kg, vitamin B2 >=5.25 mg/kg, vitamin B6 >=3.15 mg/kg, vitamin B12 >=0.015
Mg/kg, biotin >=0.105 mg/kg, nicotinic acid >=23 mg/kg, pantothenic acid >=8.4 mg/kg, folic acid >=0.63 mg/kg.
Calculated with feed total weight parts, each component and its mass parts in composite mineral matter trace element of the present invention
For：Copper >=6 mg/kg, iron >=52.5 mg/kg, zinc >=89 mg/kg, manganese >=84 mg/kg, iodine >=1 mg/kg, selenium >=0.2
mg/kg。
With feed total weight parts calculate, compound micro-ecological preparation of the present invention be VREF, Lactococcus lactis and
The freeze drying activity bacterium powder of bacillus subtilis, total viable count is 2 × 109More than cuf/g, these three probiotics are bought from big
Jia Shengbang biotech companies.
Linseed used in the present invention, purple perilla seed and microalgae powder are rich in omega-3 polyunsaturated fatty acids.Wherein, flax
Omega-3 polyunsaturated fatty acids in seed and purple perilla seed is mainly alpha-linolenic acid, and the 50% and 62% of its total fat is accounted for respectively, and micro-
Omega-3 polyunsaturated fatty acids in algae powder is mainly DHA and EPA, accounts for more than the 40% of its total fat.α-flax of laying hen feeding
Acid can be deposited in vivo, and be converted into DHA and EPA, so as to produce enrichment omega-3 polyunsaturated fatty acids（Mainly include α-flax
Acid, DHA and EPA）Egg.
Purslane used in the present invention contains the various bioactivators such as organic acid, flavones, polysaccharide, cumarin, tool
There are Adjust-blood lipid, hypoglycemic, anti-ageing function of waiting for a long time.The present invention adds Co-Q10 in feed, used as liposoluble substance, Co-Q10
Can be enriched with yolk.By scientific and reasonable compatibility, after feeding laying hen 2 weeks with the feed, total ω -3 is obtained in that
Content of polyunsaturated fatty acid is 0.5 % ~ 1.2 %, DHA（DHA）Content is 0.12 % ~ 0.25 %, coenzyme
Q10 contents are the egg of 2.5 ~ 4.0 micro- gram grams, its content is respectively 7.1 ~ 17.1 times of common egg, 3.0 ~ 6.3 times, 2.5 ~
4.0 times.Additionally, the egg shelf-stable for being obtained, it is easy to promote.Often eat this rich in omega-3 polyunsaturated fatty acids and auxiliary
The functional Egg of enzyme Q10, has important health-care effect for modern, especially the elderly, can prevent heart and brain blood
Pipe disease, anti-aging, raising immunity of organisms etc..
Specific embodiment
The present invention is further illustrated below in conjunction with example.
The preparation of the functional premixing material of specific embodiment 1
（1）Prepare purslane：Fresh purslane is taken, undesirable root and impurity is removed, first freeze overnight, to subzero less than 5 DEG C, further takes out
Drying 2 hours.Purslane after drying is crushed stand-by with 8.0 mm sieves.
（2）Purity is 98% Co-Q10, purchased from Zhejiang NHU Company Ltd；Compound micro-ecological preparation purchase is certainly
Whiskas Sheng Bang Bioisystech Co., Ltd
（3）The preparation of B B-complex：Take feed grade vitamine supplement retinyl acetate（The IU/g of specification 500,000）：300 millis
Gram, vitamine D3（The IU/g of specification 500,000）：110 milligrams, vitamin E：500 milligrams, Vitamin K3：25 milligrams, vitamin B1：35
Milligram, vitamin B2：110 milligrams, vitamin B6：55 milligrams, vitamin B12：0.3 milligram, biotin：1.7 milligrams, nicotinic acid：
420 milligrams, pantothenic acid：140 milligrams, folic acid：12 milligrams, 3291 milligrams of carrier powdered rice hulls be well mixed, be made B B-complex and treat
With.
（4）The preparation of composite mineral matter trace element：Take the g of feed grade trace mineral supplement cupric sulfate pentahydrate 0.45, sulphur
It is ferrous 2.4 g of acid, the g of white vitriol 7.4, the g of manganese sulfate monohydrate 3.5,28 milligrams of Potassiumiodate, 7.5 milligrams of sodium selenite, micro
The g of element carrier zeolite powder 11.215 is well mixed, and is prepared into composite mineral matter trace element stand-by.
（5）Compound micro-ecological preparation：Probiotics is directly bought from Whiskas Sheng Bang Bioisystech Co., Ltd, is directly added
Plus.
（6）The preparation of functional premixing material：Take Co-Q10：0.4 g, microalgae powder：15 g, purslane：10 g, phosphoric acid hydrogen
Calcium：12 g, purity are 50% Choline Chlorides：3 g, salt：3.5 g, DL- METHIONINE：1.3 g, phytase：0.07 g, antioxygen
Agent ethoxyquinoline：0.3 g, B B-complex：0.35 g, composite mineral matter trace element：2 g, compound micro-ecological preparation：
1.2 g, carrier zeolite powder：5.88 g, are mixed uniform stand-by.
The preparation of feed of the production rich in omega-3 polyunsaturated fatty acids and Co-Q10 egg of specific embodiment 2
Feed of the production rich in omega-3 polyunsaturated fatty acids and Co-Q10 egg is by the beans of 550 g corns, 200 g 46%
The dregs of rice, 5 g soybean oils, 50 g linseeds, 40 g purple perilla seeds, 20 g alfalfa meals, 90 g stone flours, 45 g functional premixing material groups
Into.
The preparation of feed of the production rich in omega-3 polyunsaturated fatty acids and Co-Q10 egg of specific embodiment 3
Feed of the production rich in omega-3 polyunsaturated fatty acids and Co-Q10 egg is by the beans of 520 g corns, 190 g 46%
The dregs of rice, 10 g soybean oils, 60 g linseeds, 50 g purple perilla seeds, 30 g alfalfa meals, 80 g stone flours, 60 g functional premixing material groups
Into.
The preparation of feed of the production rich in omega-3 polyunsaturated fatty acids and Co-Q10 egg of specific embodiment 4
Feed of the production rich in omega-3 polyunsaturated fatty acids and Co-Q10 egg is by the beans of 490 g corns, 180 g 46%
The dregs of rice, 15 g soybean oils, 80 g linseeds, 50 g purple perilla seeds, 50 g alfalfa meals, 80 g stone flours, 55 g functional premixing material groups
Into.
The preparation of the control group feed of specific embodiment 5
The feed of control group is made up of 620 g corns, 240 g dregs of beans, 5 g soya-bean oil, 90 g stone flours, 45 g premixes.
Wherein, the premix be by the g of calcium monohydrogen phosphate 13, purity 50% the g of Choline Chloride 3, salt 3.5 g, DL-
The g of methionine 1.3, the g of phytase 0.07, the g of antioxidant 0.3, the g of B B-complex 0.2,2 g of composite mineral matter trace element
Mixed with the g of carrier zeolite powder 21.63.
Specific embodiment 6 contrasts feeding experiment
From 1200 blue ash laying hens in health sea of 25 week old, 2 treatment groups, every group of 6 repetitions, each repetition are randomly divided into
100 chickens.Test group 1 and 2 feeds implementation method 5 respectively（Control group）With implementation method 3（Test group）The feed of preparation.Prerun
1 week phase, formal test 4 weeks is specifically carried out on the October 13rd, 8 days 1 of September in 2016.
Feeding and management：Raised according to the blue brown commercial generation feeding and management handbook requirement in sea.
Testing index：
（1）Performance test：
During experiment, laid eggs weight, egg number with being repeated as unit record daily, and calculate average egg weight and laying rate, weekly with
Repeat to calculate feed intake and feedstuff-egg ratio for unit.
（2）Egg Quality is determined：
Egg is collected in units of repetition in last day preliminary trial period, formal test the 2nd week, the last day of the 4th week, each weight
Multiple 20 pieces of eggs, for determining egg size, eggshell color, egg shape index, shell thickness, eggshell strength, yolk ratio, yolk face
The Egg Quality index such as color, hangh unit.
Additionally, collecting egg in units of repetition in the last day of formal test the 4th week, each repeats 20 pieces of eggs,
Egg is placed in room temperature（24~26℃）After storing 3 weeks, determined for Egg Quality.
（3）Aliphatic acid constitutes the measure with Co-Q10 content：
At the weekend of formal test the 4th, egg is collected in units of repetition, each repeats 4 pieces, the yolk of this 4 pieces of eggs is separated
And mix, lyophilized yolk powder is then made of freeze dryer.Lyophilized yolk powder is sent to country of Ministry of Agriculture feed industry Spot detection fat
The composition of fat acid and the content of Co-Q10, the composition of wherein aliphatic acid detected with gas chromatography, and Co-Q10 contains
Amount is detected with high performance liquid chromatography.
Data statistical approach：
Test data is arranged with Excel, and variance analysis is carried out using the One-Way ANOVA of the statistical softwares of SPSS 20.0, while
Multiple range test is carried out using Duncan ' s,P<0.05 represents significant difference.
Result of the test：
（1）Influence of the feed of the present invention of table 1 to performance in layers
Note：Subscript difference represents significant difference, is represented without significant difference without subscript, similarly hereinafter.
The data display of table 1, test group is consistent in the production performance of pre-feeding period with control group, and within whole experimental period,
The production performance such as its laying rate, egg size, feed intake and feedstuff-egg ratio index illustrates that feeding is rich in for production without significant difference
The feed of omega-3 polyunsaturated fatty acids and Co-Q10 egg does not influence performance in layers.
（2）Influence of the feed of the present invention of table 2 to egg Egg Quality
Note：Subscript difference represents significant difference, is represented without significant difference without subscript, similarly hereinafter.
The data display of table 2, test group is identical in the egg quality of pre-feeding period with control group.At experiment the 2nd weekend, the 4th week
End, and normal temperature storage, after 3 weeks, the yolk color of test group is all remarkably higher than control group, illustrates to be rich in day in feed of the present invention
Right lutein, and effectively can deposit in yolk, so as to improve yolk color.In addition to yolk color, test group and control group
The equal nothing of Egg Quality index such as egg size, eggshell color, egg shape index, shell thickness, eggshell strength, yolk ratio and hangh unit
Significant difference, illustrates to be fed for producing the feed rich in omega-3 polyunsaturated fatty acids and Co-Q10 egg to chicken to laying hen
Egg Egg Quality has no adverse effects, and can improve yolk color.Because omega-3 polyunsaturated fatty acids contains how unsaturated double bond, hold
It is oxidizable, therefore in general the egg rich in omega-3 polyunsaturated fatty acids is difficult storage.But, the chicken that the present invention is produced
After egg normal temperature storage 3 weeks, without significant difference compared with control group, and yolk color is significantly higher than control to Egg Quality index
Group, illustrates that the egg antioxygenic property that is produced of the present invention is good, shelf-stable, thus easy to spread.
（3）Table 3 feeds the aliphatic acid composition and Co-Q10 content that feed of the present invention produces egg
Note：Subscript difference represents significant difference, is represented without significant difference without subscript, similarly hereinafter.
The data display of table 3, egg obtained by feeding experiment group daily ration, the mg/ of omega-3 polyunsaturated fatty acids content 998
100g, DHA218 mg/100g, the μ g/g of Co-Q10 3.10, therefore, omega-3 polyunsaturated fatty acids content is 0.998%, DHA
Content is 0.218%, and Co-Q10 content is 3.10 μ g/g, and the content of its omega-3 polyunsaturated fatty acids, DHA and Co-Q10 is equal
Control group is significantly higher than, is respectively 13.3 times, 4.6 times and 3 times of control group, illustrate that feeding daily ration of the present invention can be rich in
The egg of omega-3 polyunsaturated fatty acids and Co-Q10.
Additionally, confirmed through lot of experiments, with feed Direct-fed laying hen of the present invention 2 weeks after, can obtain total ω -3 many
Unsaturated fatty acid content is 0.5 % ~ 1.2 %, DHA（DHA）Content is 0.12 % ~ 0.25 %, Co-Q10
Content is the egg of 2.5 ~ 4.0 micro- gram grams, its content is respectively 7.1 ~ 17.1 times of common egg, 3.0 ~ 6.3 times, 2.5 ~ 4.0
Times.
In sum, the present invention provides a kind of feed produced rich in omega-3 polyunsaturated fatty acids and Co-Q10 egg
And products obtained therefrom, by the reasonable compatibility of linseed, purple perilla seed, alfalfa meal and functional premixing material, obtain that there is the prevention heart
The functional Egg of the health-care effects such as cranial vascular disease, anti-aging, raising immunity of organisms, and feed feed pair of the present invention
The production performance and Egg Quality of laying hen have no adverse effects.
Claims (10)
1. it is a kind of to produce the feed for being rich in omega-3 polyunsaturated fatty acids and Co-Q10 egg, it is characterised in that by following main
Into being grouped into：Corn, dregs of beans, soybean oil, linseed, purple perilla seed, alfalfa meal, stone flour, functional premixing material.
2. feed according to claim 1, it is characterised in that the mass parts of the main component are：Corn 490 ~ 550
Part, 180 ~ 200 parts of dregs of beans, 5 ~ 15 parts of soybean oil, 50 ~ 100 parts of linseed, 10 ~ 80 parts of purple perilla seed, 20 ~ 50 parts of alfalfa meal, stone
80 ~ 90 parts of powder, 45 ~ 60 parts of functional premixing material.
3. feed according to claim 1 and 2, it is characterised in that the mass parts of the main component be 490 parts of corn,
180 parts of dregs of beans, 15 parts of soybean oil, 80 parts of linseed, 50 parts of purple perilla seed, 50 parts of alfalfa meal, 80 parts of stone flour, functional premixing material
55 parts.
4. the feed according to any one of claim 1 ~ 3, it is characterised in that the main component is in every kilogram of feed
Mass parts are the g of corn 490, the g of dregs of beans 180, the g of soybean oil 15, the g of linseed 80, the g of purple perilla seed 50, the g of alfalfa meal 50, stone
The g of powder 80, the g of functional premixing material 55.
5. the feed according to any one of claim 1 ~ 4, it is characterised in that the functional premixing material constituent is：
Co-Q10, microalgae powder, purslane, calcium monohydrogen phosphate, Choline Chloride, salt, DL- METHIONINE, phytase, antioxidant, compound dimension
Raw element, composite mineral matter trace element and compound micro-ecological preparation.
6. feed according to claim 5, it is characterised in that the mass parts of the constituent of the functional premixing material
For：Co-Q10 using 0.2 ~ 0.6 part, 10 ~ 20 parts of microalgae powder, 5 ~ 15 parts of purslane, 12 ~ 14 parts of calcium monohydrogen phosphate, Choline Chloride 1 ~
3 parts, 3.0 ~ 3.5 parts of salt, 1 ~ 2 part of DL- METHIONINE, 0.05 ~ 0.1 part of phytase, 0.2 ~ 0.4 part of antioxidant, compound dimension life
0.2 ~ 0.35 part of element, 2 ~ 2.5 parts of composite mineral matter trace element, 1 ~ 1.5 part of compound micro-ecological preparation, remainder are carrier.
7. feed according to claim 6, it is characterised in that the constituent of the B B-complex is：Vitamin A,
It is vitamine D3, vitamin E, Vitamin K3, vitamin B1, vitamin B2, vitamin B6, vitamin B12, biotin, nicotinic acid, general
Acid, folic acid.
8. feed according to claim 6, it is characterised in that the constituent of the composite mineral matter trace element is：
Copper, iron, zinc, manganese, iodine, selenium.
9. feed according to claim 6, it is characterised in that the constituent of the compound micro-ecological preparation is：Dung intestines
Coccus, Lactococcus lactis and bacillus subtilis.
10. it is a kind of to produce the feed for being rich in omega-3 polyunsaturated fatty acids and Co-Q10 egg, it is characterised in that by this feed
After Direct-fed laying hen 2 weeks, total omega-3 polyunsaturated fatty acids content is can obtain for 0.5 % ~ 1.2 %, 22 carbon six
Olefin(e) acid（DHA）Content is 0.12 % ~ 0.25 %, and Co-Q10 content is the egg of 2.5 ~ 4.0 micro- gram grams.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710127314.1A CN106858141A (en) | 2017-03-06 | 2017-03-06 | A kind of feed produced rich in the polyunsaturated fatty acids of ω 3 and Co-Q10 egg |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710127314.1A CN106858141A (en) | 2017-03-06 | 2017-03-06 | A kind of feed produced rich in the polyunsaturated fatty acids of ω 3 and Co-Q10 egg |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106858141A true CN106858141A (en) | 2017-06-20 |
Family
ID=59170766
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710127314.1A Pending CN106858141A (en) | 2017-03-06 | 2017-03-06 | A kind of feed produced rich in the polyunsaturated fatty acids of ω 3 and Co-Q10 egg |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106858141A (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107494985A (en) * | 2017-09-27 | 2017-12-22 | 新奥科技发展有限公司 | A kind of microalgae feed and preparation method thereof |
| CN108902040A (en) * | 2018-08-02 | 2018-11-30 | 四川科为民生物技术有限公司 | A kind of cultural method laid eggs rich in ω -3PUFAs thin and small hen |
| CN109123173A (en) * | 2018-06-07 | 2019-01-04 | 昆明藻能生物科技有限公司 | A kind of functional egg production method rich in DHA, astaxanthin and Co-Q10 |
| CN109198237A (en) * | 2018-09-13 | 2019-01-15 | 重庆滂渤农业科技有限公司 | A kind of chicken feed rich in algae oil and bacillus subtilis |
| CN112401067A (en) * | 2020-09-27 | 2021-02-26 | 天津农学院 | Feed additive for increasing deposition amount of coenzyme Q10 in egg yolk and application thereof |
| CN112641011A (en) * | 2020-12-28 | 2021-04-13 | 太仓安佑生物科技有限公司 | Chicken feed rich in Omega-3 and application method thereof |
| ES2925125A1 (en) * | 2021-03-30 | 2022-10-13 | Cellbitec S L | Food and functional use of Ocimum basilicum seed oil (Machine-translation by Google Translate, not legally binding) |
| ES2925293A1 (en) * | 2021-03-30 | 2022-10-14 | Cellbitec S L | Nutraceutical formulation indicated to reduce the risk of suffering diseases related to chronic inflammation and oxidative stress (Machine-translation by Google Translate, not legally binding) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008082369A2 (en) * | 2006-12-29 | 2008-07-10 | Kemijski Institut | Use of coenzyme q10 for improved effectiveness of animal husbandry and production of animal tissues with an increased content of the said coenzyme |
| JP2010148380A (en) * | 2008-12-24 | 2010-07-08 | Kaneka Corp | Reduced coenzyme q10-containing egg |
| CN102919579B (en) * | 2012-10-30 | 2014-02-19 | 王云 | Eggs rich in omega-3 polyunsaturated fatty acids and preparation method |
-
2017
- 2017-03-06 CN CN201710127314.1A patent/CN106858141A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008082369A2 (en) * | 2006-12-29 | 2008-07-10 | Kemijski Institut | Use of coenzyme q10 for improved effectiveness of animal husbandry and production of animal tissues with an increased content of the said coenzyme |
| JP2010148380A (en) * | 2008-12-24 | 2010-07-08 | Kaneka Corp | Reduced coenzyme q10-containing egg |
| CN102919579B (en) * | 2012-10-30 | 2014-02-19 | 王云 | Eggs rich in omega-3 polyunsaturated fatty acids and preparation method |
Non-Patent Citations (2)
| Title |
|---|
| 张莺莺等: "《蛋鸡生产技术问答》", 30 June 2014, 郑州：河南科学技术出版社 * |
| 赖来展等: "《黑色食品与健康长寿》", 31 October 2014, 北京：金盾出版社 * |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107494985A (en) * | 2017-09-27 | 2017-12-22 | 新奥科技发展有限公司 | A kind of microalgae feed and preparation method thereof |
| CN109123173A (en) * | 2018-06-07 | 2019-01-04 | 昆明藻能生物科技有限公司 | A kind of functional egg production method rich in DHA, astaxanthin and Co-Q10 |
| CN108902040A (en) * | 2018-08-02 | 2018-11-30 | 四川科为民生物技术有限公司 | A kind of cultural method laid eggs rich in ω -3PUFAs thin and small hen |
| CN109198237A (en) * | 2018-09-13 | 2019-01-15 | 重庆滂渤农业科技有限公司 | A kind of chicken feed rich in algae oil and bacillus subtilis |
| CN112401067A (en) * | 2020-09-27 | 2021-02-26 | 天津农学院 | Feed additive for increasing deposition amount of coenzyme Q10 in egg yolk and application thereof |
| CN112641011A (en) * | 2020-12-28 | 2021-04-13 | 太仓安佑生物科技有限公司 | Chicken feed rich in Omega-3 and application method thereof |
| ES2925125A1 (en) * | 2021-03-30 | 2022-10-13 | Cellbitec S L | Food and functional use of Ocimum basilicum seed oil (Machine-translation by Google Translate, not legally binding) |
| ES2925293A1 (en) * | 2021-03-30 | 2022-10-14 | Cellbitec S L | Nutraceutical formulation indicated to reduce the risk of suffering diseases related to chronic inflammation and oxidative stress (Machine-translation by Google Translate, not legally binding) |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106858141A (en) | A kind of feed produced rich in the polyunsaturated fatty acids of ω 3 and Co-Q10 egg | |
| CN101455278B (en) | Big-broiler feedstuff and preparation method thereof | |
| CN102696869B (en) | Production method for eggs rich in DHA and Vitamin E ingredients | |
| CN101181018B (en) | Hen feedstuff for producing healthy egg | |
| CN103330055B (en) | Feed for regulating and controlling color of yolk of egg and cholesterol and production method of feed | |
| CN1247107C (en) | Egg chicken nutrious feed | |
| CN102389029B (en) | Laying hen composite premix for prolonging egg laying peak time | |
| JP2011516054A (en) | Long-chain polyunsaturated fatty acids (LC-PUFA) in maternal nutrition during pregnancy and lactation | |
| CN107981087A (en) | Improve feed of laying hen Egg Quality and preparation method thereof | |
| CN109123183A (en) | A kind of broiler fodder | |
| CN102783587A (en) | Chicken feed additive capable of reducing cholesterol and increasing lecithin of eggs | |
| CN102578437B (en) | Snail feed nutrient | |
| CN102018119A (en) | Health-care crucian feed and preparation method thereof | |
| CN102018117A (en) | Grass carp feedstuff and preparation method thereof | |
| CN102894232A (en) | Broiler chick intestine healthcare compound feed | |
| CN102018114A (en) | Fish and shrimp feed and preparing method thereof | |
| CN102018121A (en) | Health-care grass carp feed and preparation method thereof | |
| CN103564262B (en) | Hog grower feed | |
| CN106962819A (en) | Egg rich in the polyunsaturated fatty acids of ω 3 and Co-Q10 and preparation method thereof | |
| CN102018115A (en) | Fish and shrimp feed and preparation method thereof | |
| CN108576480A (en) | A kind of composite premix feed for laying hen | |
| CN103385375A (en) | Antibiotic-free compound feed for fryers | |
| CN102018133A (en) | Carp feed and preparation method thereof | |
| CN102018124A (en) | Crucian feed and preparation method thereof | |
| CN103583462B (en) | Cherry valley meat duckbreeding method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170620 |